EARLY ACHIEVEMENT OF PARTIAL MAYO SCORE REMISSION AND IBDQ NORMALIZATION IN PATIENTS WITH ULCERATIVE COLITIS TREATED WITH FILGOTINIB IN THE PHASE 2B/3 SELECTION STUDY

Marc Ferrante  1     Alessandra Oortwijn  2     Brian G. Feagan  3     Chohee Yun  4     Jie Zhang     Laurent Peyrin-Biroulet  5     Severine Vermeire     Silvio Danese  6    
1 Department of Gastroenterology and Hepatology, University Hospitals Leuven, Leuven, Belgium
2 Galapagos NV, Leiden, Netherlands
3 Robarts Research Institute, Western University, London, ON, Canada
4 Gilead Sciences Inc., Foster City, CA, United States
5 Inflammatory Bowel Disease Unit, Nancy University Hospital, Nancy, France
6 IBD Center, Humanitas Research Hospital, Milan, Italy

Topic
IBD

Conference
UEG Week Virtual 2021

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing